GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Extendicare Inc (OTCPK:EXETF) » Definitions » EPS Growth Rate (Future 3Y To 5Y Estimate)

Extendicare (Extendicare) EPS Growth Rate (Future 3Y To 5Y Estimate) : N/A (As of Apr. 29, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Extendicare EPS Growth Rate (Future 3Y To 5Y Estimate)?

EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Extendicare's EPS Growth Rate (Future 3Y To 5Y Estimate) is N/A.


Competitive Comparison of Extendicare's EPS Growth Rate (Future 3Y To 5Y Estimate)

For the Medical Care Facilities subindustry, Extendicare's EPS Growth Rate (Future 3Y To 5Y Estimate), along with its competitors' market caps and EPS Growth Rate (Future 3Y To 5Y Estimate) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Extendicare's EPS Growth Rate (Future 3Y To 5Y Estimate) Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Extendicare's EPS Growth Rate (Future 3Y To 5Y Estimate) distribution charts can be found below:

* The bar in red indicates where Extendicare's EPS Growth Rate (Future 3Y To 5Y Estimate) falls into.



Extendicare  (OTCPK:EXETF) EPS Growth Rate (Future 3Y To 5Y Estimate) Explanation

EPS Growth Rate (Future 3Y To 5Y Estimate) s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


Extendicare EPS Growth Rate (Future 3Y To 5Y Estimate) Related Terms

Thank you for viewing the detailed overview of Extendicare's EPS Growth Rate (Future 3Y To 5Y Estimate) provided by GuruFocus.com. Please click on the following links to see related term pages.


Extendicare (Extendicare) Business Description

Industry
Traded in Other Exchanges
Address
3000 Steeles Avenue East, Suite 700, Markham, ON, CAN, L3R 9W2
Extendicare Inc is a senior care provider in Canada, focused on long-term care and home health care. The company has three main business segments namely Long-term Care, Home Health Care, and Managed Services. The Long-term Care segment, operating under the Extendicare brand, represents 53 owned homes in Ontario, Alberta and Manitoba. The Home Health Care segment, operating under the ParaMed brand, provides more than 9 million hours of home health care services annually in Ontario, Alberta, Manitoba and Nova Scotia. The Managed Services segment, operating under the Extendicare Assist and SGP Purchasing Partner Network brands, provides management, consulting and group purchasing services to other care providers across Canada.

Extendicare (Extendicare) Headlines

From GuruFocus

Extendicare Announces December 2019 Dividend of C$0.04 per Share

By GlobeNewswire GlobeNewswire 12-12-2019

Extendicare Completes Acquisition of Lynde Creek Retirement Community

By GlobeNewswire GlobeNewswire 04-11-2018

Extendicare Announces Normal Course Issuer Bid

By GlobeNewswire GlobeNewswire 06-27-2022

Extendicare Announces December 2018 Dividend of C$0.04 per Share

By GlobeNewswire GlobeNewswire 12-14-2018

Extendicare Provides Business Update Related to COVID-19

By GlobeNewswire GlobeNewswire 04-28-2020

Extendicare Appoints Dr. Michael R. Guerriere as New President and CEO

By GlobeNewswire GlobeNewswire 09-11-2018

Extendicare Announces 2020 First Quarter Results

By GlobeNewswire GlobeNewswire 05-14-2020

Extendicare Announces December 2020 Dividend of C$0.04 per Share

By GlobeNewswire GlobeNewswire 12-17-2020